DEAR
ASSOCIATES,
TODAY ECONOMY IN ANY FILED IS THE DRIVING FORCE TO
KEEP AHEAD IN COMPETITIVE RACE .THE COST OF EUROPEAN COUNTRIES
FOR CLINICAL TRIAL OR BIOEQUIVALENCE OR TOXICOLOGY STUDIES
IS MUCH-MUCH HIGHER AS COMPARED TO INDIA .7CHEMICALS
&RESEARCH ADD YET ANOTHER FEATHER IN CAP BY BECOMING
FIRST MULTIDISCIPLINARY , ADVANCED PHARMACEUTICAL
RESEARCH INSTITUTE
1.
SALIENT FEATURES:
A.
7CHEMICALS
& RESEARCH, THE FIRST MULTIDISCIPLINARY,ADVANCEDPHARMACEUTICAL
RESEARCH INSTITUTE,HAS SPECIFIC EXPERTISE AND FACILITIES
FOR THE PRECISE TESTING AND SCREENING OF DRUGS AND
FORMULAIONS.
B.
7CHEMICALS
& RESEARCH HAS DEVELOPED SPECIAL ANALYTICALMETHODOLOGY
FOR BIOEQUIVALENCE STUDIES AND UNDERTAKES BIOEQUIVALENCE
AND BIOAVAILABILITY STUDIES FOR NEW DRUGS AND GENERICS
AS PER SCHEDULE Y,ICH AND INTERNATIONAL STANDARDS.
2.
EXPERTISE AND SERVICES AVAILABLE TO THE
INDUSTRY.
PHARMACOKINETIC AND DRUG METABOLISM
STUDIES IN ANIMALS AND HUMANS.
BIOAVAILABILITY AND BIOEQUIVALENCE
STUDIES FOR NEW DRUGS AND GENERICS.
TOXICOLOGICAL EVALUATION OF DRUGS
(ACUTE AND SUBACUTE)
DEVELOPMENT AND STANDARDIZATION
OF IN VIVO AND IN VITRO MODELS FOR TOXILOGICAL EVALUTION
AND SCREENING.
DEVELOPMENT OF ANIMAL MODELS FOR
EVALUTION OF PHARMACOLOGICAL ACTIVITY OF DRUGS.
ANTI-DIABETIC,ANTI-INFLAMMATORY AND
ULCEROGENIC MODELS AVAILABLE FOR SCREENING.
HIGH THROUGHPUT SCREENING OF NEW
CHEMICAL ENTITIES FOR THEIR ANTIMICROBIAL ACTIVITY.
3.
FACILITIES :
28 BED AIR CONDITIONED CLINICAL WING
STATE OF ART INSTRUMENTATION FACILITY GCP & GLP COMPLIANCE.